Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-10-29

Clinical Trial Update: Sphenopalatine Ganglion Block with Tx360 for Trigeminal Neuralgia

View source ↗

Summary

A clinical trial update reports the completion of a study evaluating sphenopalatine ganglion block using the Tx360 device for Trigeminal Neuralgia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tx360 Sphenopalatine Ganglion Block

Snippet

Sponsor: Aretaieio Hospital | Conditions: Trigeminal Neuralgia | Status: COMPLETED